Skip to main content

Table 2 Percent reduction in mean difference and mean squared difference that correspond to: SPRI compared to all other multivariate models (a, b, and c)b; SPRI compared to SHRI (d); SPRIS compared to SHRIS (e); SPRI compared to SPRIS(f)

From: Analysis of multivariate longitudinal kidney function outcomes using generalized linear mixed models

  Estimate Outcome (a) SPRI vs SHRI (b) SPRI vs SHRIS (c) SPRI vs SPRIS (d) SPRI vs SHRld (e) SPRIS vs SHRISe (f) SPRI vs SPRISf
Mean difference Intercept BUN 4% 15% 33% 4% ()c 33%
Creatinine ()a () () 14% 89% ()c
eGFR () () () 12% 63% ()
Time BUN () () () ()c () 96%
Creatinine 84% 82% 86% 84% () 86%
eGFR 85% 85% 54% 85% 67% 74%
Mean squared difference Intercept BUN () () () () () 5%
Creatinine () () () () () 1%
eGFR () () () () () 28%
Time BUN 2% 2% 11% 2% () 11%
Creatinine 10% 9% 2% 10% 7% 2%
eGFR 32% 35% 6% 32% 31% 6%
  1. aSPRI did not generate the smallest mean difference and/or mean squared difference compared to all multivariate models.
  2. b50% of the estimates under SPRI had the smallest mean difference and mean squared difference compared to all other models with 58.7% and 12% average overall reduction respectively.
  3. cNo reduction was observed under SPRI or SPRIS.
  4. d83% of the estimates under SPRI had smaller mean difference compared to SHRI with average overall reduction of 40%, and 50% had smaller mean squared difference with average reduction of 15%.
  5. e50% of the estimates under SPRIS had smaller mean difference compared to SHRIS with average overall reduction of 73%, and 33% had smaller mean squared difference with average reduction of 19%.
  6. f66% of the estimates under SPRI had smaller mean difference compared to SPRIS with average overall reduction of 72%, and 100% had smaller mean squared difference with average reduction of 9%.